TPD52 and Miyoshi myopathy: Tumor protein D52 (TPD52) has long been reported to often be upregulated in MM [33], and our study reveals a ~2-fold decrease in TPD52 abundance (Figure 5B) which may broadly impact cellular metabolism via its reported role in regulating AMPK [34] or impacting cellular secretion [35].